Alembic Pharmaceuticals secures USFDA approval for new Paliperidone extended-release tablets

Pallavi Madhiraju- September 28, 2024 0

Alembic Pharmaceuticals Limited has achieved a major milestone in the pharmaceutical industry. On September 27, 2024, the company proudly announced that it received final approval ... Read More

AbbVie to acquire Cerevel Therapeutics for $8.7bn to expand neuroscience research

Pallavi Madhiraju- December 7, 2023 0

AbbVie Inc. (NYSE: ABBV) and Cerevel Therapeutics (NASDAQ: CERE) have announced a definitive agreement in which AbbVie will acquire Cerevel Therapeutics. The transaction, valued at ... Read More

Teva Pharmaceuticals, MedinCell get UZEDY FDA approval for schizophrenia

Pallavi Madhiraju- April 30, 2023 0

Teva Pharmaceuticals and MedinCell have bagged approval for UZEDY (risperidone) extended-release injectable suspension from the US Food and Drug Administration (FDA) for schizophrenia treatment in ... Read More

Glenmark Pharmaceuticals gets FDA final approval for Compazine generic

Pallavi Madhiraju- March 20, 2023 0

Glenmark Pharmaceuticals has bagged final approval for Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg from the US Food & Drug Administration (FDA). The ... Read More

Zydus Lifesciences gets FDA final approval for Olanzapine tablets

Pallavi Madhiraju- March 11, 2023 0

Zydus Lifesciences said that it has secured final approval for Olanzapine Orally Disintegrating Tablets USP, 5 mg, 10mg, 15 mg, and 20 mg from the ... Read More

Lupin launches schizophrenia drug Invega generic in US

Pallavi Madhiraju- October 21, 2022 0

Indian pharma company Lupin Limited has launched Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg in the US. The product is ... Read More

Zydus Lifesciences bags FDA approval for Cariprazine generic

pallavi123- September 17, 2022 0

Zydus Lifesciences (previously Cadila Healthcare) said that its American subsidiary — Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration ... Read More

Zydus Cadila gets FDA tentative approval for Cariprazine Capsules

pallavi123- December 12, 2021 0

Zydus Cadila said that its subsidiary Zydus Pharmaceuticals (USA) has secured tentative approval from the US Food and Drug Administration (FDA) to commercialize Cariprazine Capsules ... Read More

Unichem Laboratories gets FDA approval for Aripiprazole Tablets, USP

pallavi123- July 1, 2021 0

Unichem Laboratories said that it has secured a tentative approval for abbreviated new drug application (ANDA) of Aripiprazole Tablets, USP, 2mg, 5mg, 10mg, 15mg, 20mg, ... Read More

Zydus Cadila gets FDA approval for Fluphenazine Hydrochloride Tablets

pallavi123- May 29, 2021 0

Cadila Healthcare (also known as Zydus Cadila) said that it has secured final approval from the US Food and Drug Administration (FDA) to market Fluphenazine ... Read More